MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 39 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $6,882,000 | +88.1% | 1,156,626 | +100.0% | 0.39% | +28.3% |
| Q1 2022 | $3,658,000 | +74.0% | 578,313 | +7.6% | 0.31% | +120.9% |
| Q4 2021 | $2,102,000 | -20.7% | 537,584 | -2.1% | 0.14% | -28.4% |
| Q3 2021 | $2,651,000 | -24.4% | 548,836 | 0.0% | 0.19% | -22.4% |
| Q2 2021 | $3,507,000 | +1.4% | 548,836 | -0.3% | 0.25% | -36.2% |
| Q1 2021 | $3,458,000 | -5.6% | 550,679 | +3.6% | 0.39% | -32.3% |
| Q4 2020 | $3,662,000 | +78.5% | 531,510 | 0.0% | 0.58% | +60.4% |
| Q3 2020 | $2,052,000 | – | 531,510 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 869,354 | $2,895,000 | 3.47% |
| 22NW, LP | 1,241,896 | $4,136,000 | 2.24% |
| Newtyn Management, LLC | 1,199,606 | $3,995,000 | 1.46% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 186,198 | $620,000 | 0.35% |
| Yakira Capital Management, Inc. | 66,934 | $223,000 | 0.10% |
| Sepio Capital, LP | 210,534 | $701,000 | 0.08% |
| Nantahala Capital Management | 747,635 | $2,490,000 | 0.08% |
| Watson Rebecca | 3,068 | $10,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61,700 | $205,000 | 0.00% |
| WEBSTER BANK, N. A. | 3,055 | $10,000 | 0.00% |